GlassScriptPhysician profile
Judith D Larkin
NPI 1306063193
$3,121.51
in general payments reported to CMS, 2019-2025
25 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,279 · 2022: $1,306 · 2023: $486 · 2024: $50.74.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $426 · Education: $111.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $425.63 |
| Education | $111.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $509.34 | 2021-2023 | Tysabri |
| Emd Serono, INC. | $450.55 | 2021-2024 | Mavenclad |
| Novartis Pharmaceuticals Corporation | $449.10 | 2021-2023 | |
| Abbvie INC. | $295.36 | 2021-2024 | |
| Amgen INC. | $251.93 | 2021-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $203.79 | 2022 | |
| Ucb, INC. | $162.51 | 2021-2023 | Briviact |
| Bayer Healthcare Pharmaceuticals INC. | $149.24 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $103.74 | 2022 | |
| Sk Life Science, INC. | $69.75 | 2021-2022 | |
| Teva Pharmaceuticals USA, INC. | $66.76 | 2022-2023 | Austedo Xr, Austedo |
| Mallinckrodt Hospital Products INC. | $52.78 | 2021 | |
| Genentech USA, INC. | $44.66 | 2022 | |
| Sunovion Pharmaceuticals INC. | $43.69 | 2021 | |
| Banner Life Sciences, LLC | $43.16 | 2022 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurelis, INC. | $36.89 | 2021-2022 | |
| Biohaven Pharmaceuticals, INC. | $33.39 | 2021 | |
| Acorda Therapeutics, INC | $29.93 | 2021 | |
| Livanova USA, INC. | $26.20 | 2023 | Vns Therapy Sentiva Model 1000 Generator |
| Kyowa Kirin, INC. | $20.90 | 2021 | |
| Alexion Pharmaceuticals, INC. | $20.62 | 2022 | |
| Janssen Pharmaceuticals, INC | $15.78 | 2022 | |
| Medtronic, INC. | $15.30 | 2022 | |
| Supernus Pharmaceuticals, INC. | $13.37 | 2021 | |
| Lilly USA, LLC | $12.77 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Judith Larkin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.